PER percheron therapeutics limited

Ann: Notices received under S203D and S249D of Corporations Act, page-152

  1. 74 Posts.
    lightbulb Created with Sketch. 13
    Just to clarify, post 31 December according to the PVL substantial holder notifications, PVL have invested over $700k in Percheron.

    Also need to consider the ongoing costs of the companies that were incorporated just prior to the end of the half year (these ongoing costs would not be recognisable in the half year due to when they were added to PVL) and the recent appointments of David McNamee as an employee (Chief Investment Officer & Portfolio Manager) and Richard Rouse (Head of Powerhouse Advisory) and any other staff that were bought on.

    Very difficult to ascertain what the ongoing costs will be for the business at this early stage, but based on the above, it will be more than is represented in the half year accounts.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $5.924K 592.3K

Buyers (Bids)

No. Vol. Price($)
1 4056872 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 3672467 5
View Market Depth
Last trade - 15.43pm 16/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.